19985-09-2 Usage
Uses
Used in Pharmaceutical Formulation:
1-Isopropyl-pyrrolidin-3-ylamine Dihydrochloride is used as an active ingredient or a key component in the formulation of various pharmaceuticals. Its presence in these medications can contribute to their therapeutic effects and overall efficacy.
Used in Chemical Synthesis Procedures:
In the field of chemistry, 1-Isopropyl-pyrrolidin-3-ylamine Dihydrochloride is employed as a reagent or an intermediate in the synthesis of other complex molecules. Its unique structure allows it to participate in various chemical reactions, facilitating the creation of new compounds with potential applications in different industries.
Used in Scientific Research:
1-Isopropyl-pyrrolidin-3-ylamine Dihydrochloride is utilized as a research tool in various scientific studies. Its properties and reactivity make it a valuable compound for investigating chemical reactions, exploring new synthesis pathways, and understanding the mechanisms of action in biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 19985-09-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,9,8 and 5 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 19985-09:
(7*1)+(6*9)+(5*9)+(4*8)+(3*5)+(2*0)+(1*9)=162
162 % 10 = 2
So 19985-09-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H16N2.2ClH/c1-6(2)9-4-3-7(8)5-9;;/h6-7H,3-5,8H2,1-2H3;2*1H
19985-09-2Relevant academic research and scientific papers
2-PHENYL-3H-IMIDAZO[4,5-B]PYRIDINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY
-
Page/Page column 98; 100, (2016/09/22)
A compound of formula (I′) or (I′′) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of mammalian kinase enzyme activity, including ROR1 tyrosine kinase activity and may be used in the treatment of disorders associated with such activity.
THIENOPYRROLES AS ANTIVIRAL AGENTS
-
Page/Page column 36, (2008/06/13)
The present invention relates to tetracyclic thienopyrrole compounds of formula (I), wherein Ar, A, D1, D2, W, X, Y and Z are defined herein, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising them, and their use for the treatment or prevention of infection by hepatitis C virus.
